Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconRestoration

EP3212237

Metótrexat-samsetning

  • Status:
    EP Einkaleyfi fallið úr gildi
  • EP appl. date:
    28.10.2015
  • EP published:
    5.1.2022
  • EP application number:
    15790211.5
  • Max expiry date:
    27.10.2035
  • Expiry date:
    27.10.2024
  • Title in English:
    METHOTREXATE FORMULATION
  • Language of the patent:
    English

Timeline

Today
28.10.2015EP application
5.1.2022EP Publication
31.1.2022Translation submitted
15.3.2022Registration published
27.10.2024Expires

Owner

  • Name:
    Therakind Ltd.
  • Address:
    314 Regents Park Road, London, Greater London N3 2JX, GB

Inventor

  • Name:
    FRODSHAM, Michael
  • Address:
    Flintshire CH5 2NS, GB
  • Name:
    PENTON, Julie-Ann
  • Address:
    London Greater London N3 2JX, GB

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    201419261
  • Date:
    29.10.2014
  • Country:
    GB

Classification

  • Categories:
    A61K 9/00, A61K 47/10, A61K 47/12, A61K 31/519, A61P 17/00, A61P 17/06, A61P 19/02, A61P 19/04, A61P 19/08, A61P 21/00, A61P 25/00, A61P 29/00, A61P 31/10, A61P 35/00, A61P 35/02, A61P 37/06

Annual fees

Number

Paid

Expires

Payer

Number: 8

Paid: 27.10.2022

Expires: 27.10.2023

Payer: Árnason Faktor ehf.

Number: 9

Paid: 31.10.2023

Expires: 27.10.2024

Payer: Árnason Faktor ehf.

Upload documents